Overview

The Safety and Tolerability of GW805858 in Healthy Volunteers and Mild Asthmatics

Status:
Terminated
Trial end date:
2006-04-10
Target enrollment:
Participant gender:
Summary
This study will be the First Time in Human Study (FTIH) aiming to assess the safety and tolerability of GW805858 for both single and repeat dose. The study also aims to assess safety and tolerability in mild asthmatic subjects as well as healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline